Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.

ABSTRACT:

Background

Hepatocellular carcinoma accounts for approximately 80 % of liver neoplasms. Globally, hepatocellular carcinoma ranks as the third most lethal cancer, with the number of deaths expected to further increase by 2040. In adults, disparities in incidence and survival are well described while pediatric epidemiology is not well characterized. We describe incidence and survival for pediatric (ages 0-19 years) hepatocellular carcinoma cases and compare these measures to adults (ages ≥ 20 years) diagnosed with hepatocellular carcinoma.

Methods

We assessed incidence data from the US Cancer Statistics database during 2003-2020 and 5-year survival from the National Program of Cancer Registries during 2001-2019. Incidence trends were determined by annual percent change (APC) a

SUBMITTER: Arnett A 

PROVIDER: S-EPMC12409671 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature